Large-scale testing (Phase 3)Study completedNCT00814073What this trial is testingMasitinib in Severe Indolent or Smoldering Systemic MastocytosisWho this might be right forIndolent Systemic Mastocytosis AB Science 135
Large-scale testing (Phase 3)UnknownNCT05084872What this trial is testingHydroxychloroquine in Isolated Cutaneous Mastocytosis Patients or Indolent Systemic Mastocytosis With Associated Skin Involvement PatientsWho this might be right forMastocytosis University Hospital, Toulouse 30
Testing effectiveness (Phase 2)Study completedNCT03770273What this trial is testingSafety and Efficacy of Subcutaneous Sarilumab in Improving the Quality of Life in People With Indolent Systemic MastocytosisWho this might be right forIndolent Systemic Mastocytosis National Institute of Allergy and Infectious Diseases (NIAID) 21
Testing effectiveness (Phase 2)Study completedNCT02086786What this trial is testingPharmacokinetics and Tolerability Study of Risperidone ISM® in SchizophreniaWho this might be right forSchizophrenia Rovi Pharmaceuticals Laboratories 70
Early research (Phase 1)Study completedNCT01320410What this trial is testingPharmacokinetics, Safety, and Tolerance Study of Single Dose Administration of Risperidone ISM®Who this might be right forHealthy Rovi Pharmaceuticals Laboratories
Large-scale testing (Phase 3)Looking for participantsNCT04910685What this trial is testing(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic MastocytosisWho this might be right forIndolent Systemic MastocytosisSmoldering Systemic Mastocytosis Blueprint Medicines Corporation 534
Not applicableStudy completedNCT02380222What this trial is testingPatient-Reported Outcome Questionnaire for Systemic MastocytosisWho this might be right forAggressive Systemic Mastocytosis (ASM)SM w Assoc Clonal Hema Non-mast Cell Lineage Disease (SM-AHNMD)Mast Cell Leukemia (MCL)+2 more Adelphi Values LLC 5
Large-scale testing (Phase 3)Study completedNCT03160521What this trial is testingStudy to Evaluate the Efficacy and Safety of Risperidone in Situ Microparticle (ISM)® in Patients With Acute SchizophreniaWho this might be right forAcute Schizophrenia Rovi Pharmaceuticals Laboratories 438
Early research (Phase 1)Study completedNCT02808793What this trial is testingEvaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK002Who this might be right forIndolent Systemic Mastocytosis Allakos Inc. 25
Testing effectiveness (Phase 2)Study completedNCT02478957What this trial is testingTreatment of Indolent Systemic Mastocytosis With PA101Who this might be right forMastocytosisSystemic MastocytosisIndolent Systemic Mastocytosis Patara Pharma 41
Testing effectiveness (Phase 2)Active Not RecruitingNCT03731260What this trial is testing(PIONEER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, Versus Placebo in Patients With Indolent Systemic MastocytosisWho this might be right forIndolent Systemic Mastocytosis Blueprint Medicines Corporation 251
Not applicableLooking for participantsNCT06210698What this trial is testingAngioedema Biomarker Research StudyWho this might be right forAngioedemaAngioedemas, HereditaryUrticaria+5 more Foundation For Rare Disease Research 600
Not applicableNot Yet RecruitingNCT07757893What this trial is testingPrecision Medicine for Indolent Systemic Mastocytosis (PRISM)Who this might be right forSystemic Mastocytosis Mayo Clinic 25